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Abstract
Human cytolytic T lymphocytes and NK cells can limit tumor growth and are being increasingly
harnessed for tumor immunotherapy. One way cytolytic lymphocytes recognize tumor cells is by
engagement of their activating receptor, NKG2D, by stress-antigens of the MICA/B and ULBP
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families. This study shows that surface upregulation of NKG2D ligands by human epithelial cells
in response to ultraviolet irradiation, osmotic shock, oxidative stress, and growth factor provision,
is attributable to activation of the EGF-receptor (EGFR). EGFR activation causes intracellular re-
localisation of AUF1 proteins that ordinarily destabilise NKG2D ligand mRNAs by targeting an
AU-rich element conserved within the 3′ ends of most human but not murine NKG2D ligand
genes. Consistent with these findings, NKG2D ligand expression by primary human carcinomas
positively correlated with EGFR expression that is commonly hyper-activated in such tumours,
and was reduced by clinical EGFR inhibitors. Thus, stress-induced activation of EGFR not only
regulates cell growth but concomitantly regulates the cells’ immunological visibility. Thus,
therapeutics designed to limit cancer cell growth should also be considered in terms of their
impact on immunosurveillance.
Introduction
Although variation in human health is genetically determined, it is increasingly
acknowledged to be massively affected by the “exposome” which refers to the totality of
environmental challenges to which genomes equip individuals to respond (1). While the
challenge of microbial exposure has received considerable attention, inanimate components
of the exposome, collectively termed “stress”, are also important. In this regard, lymphoid
stress-surveillance describes how lymphocytes, as opposed to myeloid cells, respond rapidly
and polyclonally to endogenous molecules whose expression is substantially altered by cell
and/or tissue dysregulation (2). One molecular manifestation of this is provided by MHC
Class I-related antigens of the MICA/MICB and ULBP families in humans, and by the
murine Rae1, H60 and Mult1 genes. By engaging NKG2D, an activating receptor on NK
cells and subsets of T cells, these ligands provoke immune effector responses including
cytolysis and cytokine production, either by primary activation of responding lymphocytes,
or by co-stimulation of cells receiving signals through the T cell antigen receptor (TCR)
(3-5). By either means, NKG2D ligand up-regulation can be a major source of
immunogenicity of dysregulated cells, complementing the activities of microbe-associated
molecules such as Toll-like receptor (TLR) ligands. It therefore becomes important to
understand the mechanisms by which NKG2D ligands are regulated, since their expression
can be a key factor in determining whether or not cells become visible to the immune
system. Were NKG2D ligand expression not to be regulated appropriately, normal cells
might become targets of immune attack, potentially provoking autoinflammatory diseases
such as psoriasis, to which NKG2D ligands are conspicuously linked by genome-wide
association studies (6, 7).
NKG2D regulation and lymphoid stress-surveillance are of particular relevance to cancer
immunotherapy. Many human tumours express very high levels of MICA, MICB, and one
or more ULBPs (8), the significance of which is implied by the many immuno-evasive
mechanisms adopted by tumours as well as by viruses to suppress NKG2D-mediated
lymphocyte activation (9-11). The common association of NKG2D ligand expression with
cancer cells is consistent with evidence that murine Rae1 is upregulated in response to DNA
damage (12). Nonetheless, human NKG2D ligands showed much lower levels of
responsiveness to DNA damage (12). Moreover, MICA upregulation is frequently
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associated with scenarios such as osmotic and oxidative stress, virus infection, and increased
cellular proliferation that cannot collectively be explained by DNA damage (13-15). Hence,
the regulation of human NKG2D ligand expression merited more thorough investigation.
Another fascinating and unresolved aspect of NKG2D-dependent lymphoid stress-
surveillance is the multiplicity of ligands (e.g. human MICA, MICB, ULBP1-6) (16), which
appear functionally non-redundant despite their all engaging the same receptor (17). One
hypothesis is that multiple ligands permit multiple means of regulation, enabling the host to
respond to myriad components of the exposome and collectively confounding immuno-
evasive strategies (18). Consistent with this, murine Rae1 genes but not Mult1 or H60 genes
were expressed by primary fibroblasts upon explant to culture (19). In sum, there may be
forms of regulation that apply to all NKG2D ligands and those that apply to only one or few.
The stress-responsiveness of MICA was first implied by the identification of a heat shock
response element in the MICA promoter (20). Thus, many studies have focussed on NKG2D
ligand gene transcription, including recent work showing regulation of murine Rae1 by the
E2F transcription factor (19, 21). This notwithstanding, the profound impact of NKG2D
ligands on cellular recognition by T lymphocytes and NK cells makes it probable that they
are regulated at multiple levels. Consistent with this, some human NKG2D ligand mRNAs
could be regulated under specific circumstances via micro-RNA (miR) docking sites in their
3′ untranslated regions (22, 23). Furthermore, disease-associated allelic variation in MICA
was shown to profoundly affect the post-transcriptional stability of MICA mRNA with
directly proportionate affects on surface protein expression (5).
Given these various considerations, this study re-assessed human NKG2D ligand regulation
in epithelial cells. The surprising result was that the regulation of MICA by a broad
spectrum of challenges could be more readily attributed to activation of the Epidermal
Growth Factor (EGF) receptor than to DNA damage. This mode of regulation applied
generally to human NKG2D ligand genes, albeit with slight variation in mechanism, but did
not apply to most murine NKG2D ligand genes. Because the EGFR pathway is one of the
most frequently dysregulated and commonly targeted pathways in human cancer (24), this
study directly links tumour cell surveillance by T cells and NK cells to a major cell-
autonomous component of cancer progression that is also a prime target of cancer therapy.
Results
UVB induces human NKG2D ligand upregulation
Because the murine NKG2D ligand, Rae1, is regulated by DNA damage, MICA expression
was measured following UVB treatment of human keratinocytes, the cell-type from which
MICA cDNA was originally cloned (25, 26). Although immortalised, the human HaCat
keratinocyte cell line maintains striking contact-dependent inhibition of growth at
confluence and expresses little MICA mRNA, thus permitting the gene’s upregulation by
environmental agents to be studied. However, because MICA expression can be perturbed
by changes in cell growth conditions, all experiments were meticulously controlled (see
Materials and Methods).
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Acute exposure to 60mJ/cm2 of UVB (equivalent to twice the minimal erythematous dose)
taking approximately 1-2 minutes, reproducibly upregulated total MICA protein expression
to levels comparable to those induced by acute heat shock, the prototypic means of MICA
upregulation (Figure 1A). Quantitative RT-PCR was used to measure MICA RNA relative
to GAPDH RNA that was previously demonstrated to be extremely stable in response to
UVB, including in HaCat cells (27-30). In each of nine independent experiments, MICA
RNA was significantly upregulated, in several cases by >10-fold (comparable to the levels
of protein induction shown in Fig 1A), and in other cases by 3-5-fold (Figure 1B). This
response was not limited to HaCat cells, since MICA RNA was also significantly
upregulated by UVB in four independent experiments using Int407, a foetal human intestinal
epithelial cell line that also shows strict growth control (Figure 1B). It might be argued that
UVB irradiation provoked MICA mRNA up-regulation via transient heat shock. However,
this was not compatible with the observation that whereas MICA mRNA levels induced by
heat shock peaked within 2h and returned almost to normal by 24h, those induced by UVB
did not peak until after 24h (Figures S1A, S1B). UVB-induced NKG2D ligand upregulation
extended to cultured primary human keratinocytes where increases in cell surface protein
were detected using either an antibody specific for both MICA and MICB or one specific for
ULBP2 (Figure 1C).
To examine the impact of other genotoxic stresses on MICA mRNA, HaCat cells were
treated with doxorubicin, which intercalates into DNA (31); hydroxyurea that stalls or
causes collapse of DNA replication forks following inhibition of ribonucleotide reductase
(32); and 4-nitroquinoline-1-oxide (4NQO), a carcinogen that – akin to UV-light – provokes
the formation of bulky purine adducts that are targeted by the nucleotide excision repair
pathway, and which additionally induces DNA single strand breaks and alkali-labile sites
(33). Most unexpectedly none of these significantly upregulated MICA mRNA levels
(Figure 1D), although the agents were effective as judged by the upregulation of p21 RNA
(Figure S1C) that is induced by the DNA damage-dependent activation of p53 (34). Thus
MICA mRNA expression was upregulated in keratinocytes and intestinal epithelial cells by
UVB but not obviously by a mechanism relating to DNA damage.
UVB upregulates NKG2D ligand RNAs via the EGFR
UVB irradiation can induce signalling through the EGFR, the major growth regulatory
pathway for epithelial cells (35). To assess the potential contribution of this pathway to the
regulation of MICA mRNA, cells were exposed to UVB but with or without AG1478 that
inhibits several receptors with tyrosine kinase activity including EGFR. In each of five
independent experiments, AG1478 significantly inhibited UVB-induced up-regulation of
MICA mRNA (Figure 1E, left panel). Moreover, in five independent experiments in which
confluent HaCat cells were rested in serum-free medium and then treated with EGF, MICA
mRNA was sharply upregulated (Figure 1E, right panel), with kinetics and dose-dependence
very similar to an established EGF-regulated gene, the urokinase-like plasminogen activator
receptor, UPAR (36, 37) (Figure S1D). Cell surface expression of MICA/B and ULBP2
proteins was likewise induced by EGF with similar kinetics, with the most overt increase
evident between 12h and 24h post-treatment (Fig S1E).
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Consistent with the cells’ strict contact-inhibition, neither UVB nor EGF alone induced cell
cycling in confluent HaCat cells (Figure S1F), thus distinguishing this regulation of MICA
mRNA from the upregulated transcription of the MICA and ULBP2 genes induced by
increased cell division (19). The experiments were then repeated in primary murine
keratinocytes. Predictably, NKG2D ligand RNAs were upregulated by UVB irradiation:
Rae1b and H60a by >4-5-fold, and Mult1 by ~2-fold. Strikingly, however, Mult1 was the
only NKG2D ligand gene upregulated by EGF [again by ~2-fold] (Figure 1F). Thus, the
mechanism of NKG2D ligand regulation by EGF/UVB most likely reflects a property that is
shared by the Mult1, MICA/B and ULBP2 genes, but not by the Rae1b and H60a genes (see
below).
EGFR promotes NKG2D-dependent cell killing
EGF treatment of confluent HaCat cells increased surface expression of ULBP2 and of
MICA/B detected either with a widely-used antibody that detects both proteins, or with
mono-specific antibodies for MICA and MICB, respectively (Figures 2A, S2A), but it did
not induce expression of ULBP1 and ULBP3 which were not expressed pre-treatment
(Figure 2A). Either EGF does not upregulate NKG2D ligands de novo, or it specifically does
not regulate ULBP1 and 3. This was clarified by showing that EGF upregulated ULBP1, 2,
and 3, and to a lesser extent MICA/B proteins on the surface of Caco-2 cells, an
immortalised human intestinal epithelial cell line that like HaCat shows strong contact-
dependent growth inhibition at confluence (Figure 2A). Thus, over the course of 12-24h
EGF upregulated the surface display of several human NKG2D ligands in two distinct
epithelial cell types but was seemingly more effective at increasing the level of expressed
ligands rather than inducing ligands de novo. No EGF-mediated NKG2D ligand
upregulation was shown by HCT116 cells that carry a KRAS mutation preventing surface
EGFR expression (Figure 2A) (38), whereas the ligands were upregulated on both HaCat
and HCT116 cells by phorbol-12-myristate-13-acetate (PMA) that activates signalling
components downstream of EGFR (Figure S2B).
The implication of EGFR in the response of human NKG2D ligands to UVB and EGF raised
the question of whether this major tyrosine kinase receptor pathway that regulates cell
growth also contributed to the levels of ligand expression in actively growing cells.
Supporting this, dividing, sub-confluent HaCat cells treated with AG1478 showed dose-
dependent reductions in cell surface MICA/B and ULBP2 expression (Figure S2C), whereas
no such reductions were seen in HCT116 cells in which the EGFR is impaired and does not
regulate cell growth (Figure S2C).
Although the increases in NKG2D ligand surface expression were modest, they were well
within the range reported for biologically relevant miRNA-mediated regulation of MICA
and MICB (22) and typical of the levels of miRNA-mediated gene regulation more
generally. Moreover, NKG2D+ γδ T cells and NK cells can be sensitive to only small
changes in MICA expression, albeit with donor-to-donor variation (5). Therefore, to
examine whether EGF regulates this critical function of NKG2D ligands, HaCat and
HCT116 cells were treated with increasing concentrations of EGF; surface expression of
MICA/B and ULBP2 measured on aliquots of cells (Figure S2D); parallel aliquots of cells
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co-cultured with primary PBMC from three independent healthy donors; and the induced
killing potential of NK cells and γδ T cells within the PBMC measured by flow cytometry
of CD107a that comes to the cell surface as cells de-granulate cytolytic lysosomes (5).
Notwithstanding predictable donor-specific response variation, EGF-treated HaCat cells
consistently provoked greater de-granulation-dependent CD107a expression by NK cells and
γδ T cells than did control cultures (Figure 2B, Figure S3). Indeed, in some cases, ~20% of
primary NK or γδ T cells were functionally activated. These effects were NKG2D-
dependent (Figure 2B) and not attributable to relief of NK inhibition by potential EGF-
induced reductions in HLA-expression, since levels of HLA-A/B/C and -E were unaltered
by EGF (Figure S2E). Indeed, the lack of any impact on HLA refutes the hypothesis that
EGF treatment provokes generalised immune dysregulation. Of note, the lack of an EGF-
response pathway in HCT116 cells fully correlated with a failure to stimulate NK and γδ T
cell de-granulation (Figure 2B; Figure S3). In sum, EGFR-mediated regulation markedly
increased cells’ NKG2D-dependent susceptibility to cellular immune surveillance.
To investigate the generality of this regulatory pathway in relation to cell stress, cell surface
MICA, MICB and ULBP2 expression were measured on HaCat cells treated with EGF; with
sorbitol, that induces osmotic shock; and with hydrogen peroxide that induces oxidative
stress. Of note, the EGFR can be activated by sorbitol and by oxidative stress, as well as by
UV irradiation (39, 40). MICA, MICB and ULBP2 were each upregulated in an AG1478-
sensitive mechanism (Figures 2C, S4). Thus, activation of EGFR and/or a closely related
AG1478-sensitive receptor tyrosine kinase (RTK) mediates the upregulated surface
expression of human NKG2D ligands in response to multiple components of the exposome.
EGF stabilizes MICA/B RNAs via the 3′ UTR
The sustained induction of MICA mRNA by UVB and EGF, rather than its induction de
novo might reflect accumulation of stabilized mRNA. To test this, confluent HaCat cells
were treated with actinomycin D to arrest transcriptional initiation 24h after treatment with
either EGF or control medium. Northern analysis of RNAs sampled at hourly time-points
thereafter permitted quantitation relative to GAPDH. This experiment showed that MICA
and MICB mRNAs had very low half-lives in confluent cells (t1/2-MICA, ≤30 mins; t1/2-
MICB, ~1.5h), consistent with the biological importance of limiting NKG2D ligand
expression in growth-controlled cells. However, both mRNA species were substantially
stabilized by EGF-treatment (t1/2-MICA, >2h; t1/2-MICB, ≥4h) (Figures 3A, S5A).
RNA instability is commonly regulated via the 3′-untranslated region (3′UTR), in relation
to which seeding sites for micro-RNAs (miRs) mapped within the 3′UTRs of MICA/MICB
mRNAs (green annotation in Figure 3B) were shown to reduce MICA/MICB expression
(22, 23). However, the 3′ end also harbours a conspicuous AU-rich element (ARE) of the
kind that can destabilize >5% of all cellular transcripts (41, 42). By re-sequencing and re-
annotation of the 3′UTR of the MICA gene relative to published and archived sequences,
the ARE could be oriented 6 nucleotides 3′ downstream to a canonical AATAAA polyA
signal (bold, Fig 3B) relative to which a new poly-A tail addition site was identified (blue,
Fig 3B) that is 26 nucleotides downstream, consistent with the reported mammalian mRNA
range of 5-30 nucleotides (43, 44). This contrasts with the previously reported poly-A
Vantourout et al. Page 6
Sci Transl Med. Author manuscript; available in PMC 2014 October 09.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
addition site (yellow, Fig 3B), which would have been at an highly atypical distance of 71
nucleotides downstream of the AATAAA signal (Figure 3B).
To test the potential impact on gene expression of the MICA 3′UTR region, it was cloned
(starting immediately after the translational stop codon) downstream of the GFP coding
region, creating a chimeric allele termed GFP-M3U. HaCat cells transiently transfected with
GFP-M3U displayed reproducibly lower GFP expression than those transfected with
unmodified GFP, consistent with GFP being down-regulated by the MICA 3′UTR (Figure
3C). Moreover, essentially the same result was shown by other human cell lines, with in
each case there being fewer cells expressing high GFP levels (Figure S5B).
HaCat and HCT116 cells transfected with GFP and GFP-M3U constructs were then
established as stable lines by drug selection over a 2-week period during which the
expression of GFP in GFP-M3U transfectants continued to decline significantly, relative to
unmodified GFP transfectants, as judged both by mean fluorescence intensity (MFI) and
percent-cells positive (Figure S5C). However the MFI of GFP expression was significantly
upregulated in EGF-treated GFP-M3U HaCat transfectants relative to mock-treated cells,
whereas it was not upregulated in EGF-treated GFP HaCat transfectants. GFP was also not
upregulated in HCT116 cells transfected with either the GFP or GFP-M3U constructs
(Figure 3D), consistent with the refractoriness of HCT116 cells to EGF. Collectively, these
data establish that the MICA 3′UTR destabilises gene expression, but that this can be
relieved by EGF activation. Of note, AREs are conserved in all human NKG2D ligand genes
(including several MICA alleles) for which reliable 3′UTR sequences are available, and in
Mult1, the only murine NKG2D ligand tested that was regulated by EGF (Figure S6), but are
not conserved in Rae1b or H60a genes.
An AU-rich element regulates NKG2D ligands
To confirm that MICA mRNA instability was attributable to the ARE, the chimeric reporter
constructs were subject to several mutations that did not change the length of the constructs.
Individual doublet mutations (M3U-mut1, mut2, and mut3) within the ARE significantly
rescued the low expression levels of GFP-M3U expression (purple, blue, and cyan columns,
Fig S7A), whereas mutation of the overlapping miR seeding site (M3U-mut0) had a lesser
effect (red column). However, as an independent measure of mRNA destabilization, further
chimeras were generated by fusing WT and mutant versions of the MICA 3′UTR to Renilla
luciferase (Rluc) that encodes a less stable protein than GFP, thereby providing a more
direct read-out of the destabilizing effect of the 3′UTR. In these studies, the activity of a co-
introduced, unmanipulated Firefly luciferase served to normalize Rluc expression across
different transfectants. Again, relative to non-chimeric expression, luciferase levels were
greatly reduced by the 3′UTR (green column) (Figure 4A). Again, these were marginally
rescued by mutation of the overlapping miR seeding site (M3U-mut0, red column), but were
almost completely restored to normal by independent mutations of the ARE site (purple,
blue, and cyan columns) (Fig 4A). Collectively, the results obtained with chimaeric GFP and
luciferase constructs demonstrated the capacity of the MICA 3′UTR ARE to destabilize
different RNAs at steady-state, with relief of this regulation being provided by EGFR
activation.
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In considering how EGFR might promote mRNA stabilization, it was reported that several
regulators of mRNA stability that bind to AU-rich elements are regulated by MAP kinases
(MAPK) (45). Therefore, confluent HaCat cells were stimulated with EGF with or without
increasing doses of inhibitors of MEK, p38, and JNK. MEK inhibition by PD184352
recapitulated the inhibitory effects of AG1478 in a dose-dependent fashion; conversely JNK
inhibition (by SP600125) had no effect, and p38 inhibition (by SB203580) impaired EGF-
responsive upregulation of ULBP2 but not of MICA/B (Figure S7B). Thus, the EGFR-
regulated cell surface display of NKG2D ligands shows selective dependence on MAP
kinases.
AUF1 is one of the most widely implicated factors that destabilize mRNAs by binding to
AU-rich elements (46). However, the four main isoforms vary in their effects on different
genes (47), and it was therefore important to investigate whether any or all AUF1 isoforms
might regulate NKG2D ligands at steady-state. Thus, cell surface expression was measured
on HaCat cells transfected with constructs encoding each of the four AUF1 isoforms (p37,
p40, p42, p45), respectively. Relative to mock-transfected cells, or cells transfected with the
empty vector (pCR3.1), cells transfected with each of the four isoforms showed significant
reductions in cell surface MICA and MICB and ULBP2 (Figures 4B, S8).
To investigate whether EGFR-mediated rescue of NKG2D ligand expression might reflect
regulation of AUF1 by EGFR, serum-starved cells were treated with EGF with or without
signaling inhibitors, and AUF1 protein assessed. There was no measurable impact on total or
phosphorylated protein levels (Figure S9A). However, cell fractionation experiments had
previously shown that generalized MAPK activation could provoke nuclear AUF1 re-
localization to the cytoplasm (48), which is noteworthy given that deletion of the AUF1-p37
nuclear localization signal showed that nuclear import is required for AUF1-mediated
regulation of RNA turnover (49). Strikingly, EGF treatment provoked near-complete
exclusion of AUF1 from the nucleus (Figures 4C, S9B). Of note, this was prevented by
AG1478 and PD184352 that both inhibited surface upregulation of MICA/B and ULBP2, as
described above, but not by either SP600125 or SB203580, neither of which inhibited
EGFR-regulation of MICA/B (Figure S9B).
EGFR and NKG2D ligand expression correlate in human cancer
Were EGFR-mediated regulation of human NKG2D ligand mRNAs in vitro to reflect events
in vivo, overt changes in EGFR activity should be reflected in NKG2D ligand expression. In
this regard, many human carcinomas display specific dysregulation of the EGFR (24,
50-52). Thus, gene expression profiles of a collection of 172 fresh-frozen primary breast
carcinomas (53) were examined for six NKG2D ligand RNAs (note: probes for MICA were
not present on the array platform used) in relation to EGFR, the estrogen receptor (ESR1),
and HER2, that respectively represent the major growth regulatory pathways for human
breast carcinomas (54-56). Strikingly, tumors graded in the lowest quartile (B25) for their
expression of EGFR showed significantly lower expression of four of six NKG2D ligand
RNAs assayed (ULBP1, 2, 3, and 5) (Figure 5A), none of which showed any correlation
with ESR1 or HER2 expression (Figure S10A). Independently corroborating the correlation
of NKG2D ligand expression and the EGFR pathway, the expression of all NKG2D ligand
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mRNAs except ULBP4 negatively correlated with LRIG1 RNA, that encodes a negative
regulator of the EGFR (57) (Figure 5A). Furthermore, all NKG2D ligand mRNAs showed
negative correlations with HNRNPD RNA encoding AUF1, albeit that the correlations with
MICB and ULBP1 failed to reach statistical significance (Figure 5A).
Because MICA was missing from the array, its expression, together with that of MICB, was
investigated in a data-set of 26 triple-negative breast cancer cell lines (58): both genes
showed positive correlation to EGFR expression (Figure S10B). In sum, although primary
human tumours and cell lines are inevitably complex and heterogeneous, this complexity
was super-imposed upon by an expression pattern fully consistent with the regulation of the
majority of NKG2D ligand RNAs by the opposing effects of EGFR activation and AUF1.
The EGFR pathway is also a major therapeutic target in cancer. Illustrating the potential
impact of such modalities on NKG2D ligand expression, Erlotinib (a clinically employed
EGFR inhibitor) prevented the EGF-mediated upregulation of different NKG2D ligands on
confluent HaCat cells (Figures 5B, S10C). Likewise, Erlotinib reduced NKG2D ligand
expression on actively growing HaCat cells (Figures 5C, S10D) and phenocopied the effects
of AG1478 and PD184352 on both sub-confluent and confluent Caco-2 cells (Fig S11).
Analogous dose-dependent effects in sub-confluent and confluent HaCat cells were also
achieved by Cetuximab, another clinical inhibitor of EGFR (Figure S12).
Finally, the regulation of NKG2D ligand by EGFR activation and its response to erlotinib
were examined in differentiated, non-proliferative human intestinal epithelial cells. To
achieve this, Caco-2 cells (which are commonly used to model a fully differentiated human
intestinal epithelium) were grown in collagen-coated transwells in which they form
electrically resistant monolayers (59). Over a three-week period, electrical resistance was
regularly measured across a Caco-2 cell sheet seeded in this way, and when it had reached a
stable plateau of 500 Ohms the cells were transferred to serum-free medium, with or without
EGF. MICA/B and ULBP1-3 surface expression were up-regulated by EGF (Figure 5D),
demonstrating that this form of regulation can occur in a fully confluent, functional
monolayer, as might be the case at the earliest stages of human epithelial cell transformation
in vivo. These EGF-mediated increases were substantially inhibited by Erlotinib (Figure
5D).
Discussion
The NKG2D axis is increasingly viewed as a key component of host interactions with the
environment. In response to microbial and non-microbial components of the exposome,
NKG2D ligands can promote immunogenicity in the innate phase of immunity and can
activate effector/memory cells in the adaptive phase. Given these profound potentials, it was
predicted that NKG2D ligand expression would be tightly regulated. In that regard, this
study has identified a pathway by which cell surface ligand expression is restricted via post-
transcriptional regulation, in large part mediated by a consensus ARE-element that can be
destabilized by AUF1 proteins (Figure 6A). In cells experiencing environmental
perturbation by at least four components of the exposome - UVB irradiation, growth factors,
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osmotic stress, and oxidative stress - this restriction was relieved by signaling via the EGFR
that among other things induced cellular re-localisation of AUF1 (Figure 6B).
These findings are consistent with evidence that diverse environmental stress provokes the
oxidative inactivation of active sites of phosphatases that constitutively suppress EGFR
activity (35). Some quantitative variation in the levels of induction across experiments (e.g.
see Figures 1B, 1D and 1E) most likely reflects the fine balance in any cell preparation
between the activity of those phosphatases; the factors mediating RNA degradation,
including AUF1; and the levels of MAPK activity induced by various components of the
exposome. This variation notwithstanding, the increases in surface ligand expression
consistently induced by UVB and other EGFR activators were sufficient to render cells
targets for NK and γδ T cell-mediated immune surveillance.
All human NKG2D ligand transcripts for which relevant sequence data are available contain
AREs, and given that surface expression of several NKG2D ligands was regulated in
parallel with that of MICA and MICB, this mode of NKG2D ligand regulation is probably a
general one in humans. Indeed, no differential responses of surface MICA and MICB
protein were noted to any of the agents tested, although this does not preclude additional and
differential means of regulation under different circumstances. The convergence of many
different forms of stress on a common node of NKG2D ligand activation should provoke
efficient and robust immune surveillance of many potentially threatening components of the
exposome.
At the same time, the fine details of the regulation of different ligands can vary (21). Thus,
p38 inhibition shows a differential impact on ULBP2 expression compared to MICA/B, with
our ongoing studies implicating HuR in the regulation of ULBP2 but not MICA/B RNAs.
Such differential regulation is most evident in the mouse where regulation via EGFR applied
only to Mult1, the one mouse gene clearly harbouring canonical 3′ ARE sequences. It is
evident from the comparison of heat-shock and UVB regulation of MICA (Fig 1A; Fig
S1A,B) that NKG2D ligands are regulated in multiple ways. Therefore it is possible that the
DNA damage pathway and primary transcriptional control play a greater role in the
regulation of murine Rae1 and H60 than they do in the regulation of most human NKG2D
ligands. A species-specific dichotomy in the major pathways of regulation need not be
surprising since the main ligands for NKG2D in mice and humans are not strictly orthologs,
as is also the case for NK inhibitory receptors. Nonetheless, it is clearly appropriate to seek
further clarification over the mechanisms by which human NKG2D ligands may be
regulated by DNA damage. In the meantime, this study strengthens the implication of
human NKG2D ligands in human cancer biology since the EGFR pathway is one of the
most frequently dysregulated in tumors, particularly during the transformation of epithelial
cells that are among the most established targets of lymphoid stress surveillance (24).
This study has begun to describe a pathway of human NKG2D ligand regulation, but there
are as yet many gaps to fill. For example, how does AUF1 ordinarily destabilise NKG2D
ligand RNAs and how does MAPK signaling promote its re-localisation? Moreover, future
studies should examine whether disease associated allelic variation in NKG2D ligands might
affect the sensitivity to this form of gene regulation. The dissection of gene regulation
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described here is very difficult to undertake in primary cells and given the lack of
conservation of this form of regulation of NKG2D ligands in the mouse, it is equally
challenging to design appropriate animal models. In this study, differentiated Caco-2 cells
and primary human keratinocytes were used to validate key observations, but this does not
detract from the need to cross-reference to other independent data sets as much as is
possible. This was achieved here by the gene expression analysis of over 170 primary
cancers that supported the hypothesis that EFGR regulates human NKG2D ligands in vivo.
Additionally, his study has not as yet integrated different means of NKG2D ligand
regulation. For example, do conditions that upregulate MICA/B or ULBP promoter activity
also stabilize the respective RNAs or do these steps require separate regulation, perhaps as a
checkpoint averting the precocious expression of NKG2D ligands by normal cells? Related
to this, this study has not begun to ask which mechanism of regulation might be most
relevant in particular circumstances? Nonetheless, the gene expression profiling of primary
human breast cancers showed a positive correlation of most NKG2D ligands with EGFR
expression and a negative correlation with both LRIG1, an EGFR inhibitor, and HNRNPD
(AUF1), that was shown here to destabilize NKG2D ligand RNAs. These correlations are
particularly striking given the complexity that will inevitably underlie the composition of
cancer transcriptomes (60). Indeed, the correlation might argue that the impact of the EGFR
pathway may be a dominant means of NKG2D ligand regulation in vivo. Only ULBP4
showed no significant correlations with either EGFR or LRIG1, perhaps reflecting a ligand-
specific difference since ULBP4, by contrast to other ligands, showed a significant positive
correlation with HER2 that is related to but distinct from EGFR (Figure S6A). Thus, the
possibility that ULBP4 is regulated independently should be investigated. Likewise, this
study has been limited to the regulation of NKG2D ligands by the EGFR pathway, whereas
the likelihood exists that some or all NKG2D ligand genes are also regulated by MAPK-
dependent RNA stabilization downstream of other RTKs, such as the platelet-derived
growth factor receptor (PDGFR) that is likewise implicated in pathologic cellular
dysregulation.
Importantly, the evidence provided here that EGFR activation can modulate NKG2D ligand
expression in confluent cells independent of cell proliferation offers a mechanism of
immune surveillance that may be relevant to the early stages of cancer when the EGFR
pathway and/or EGF levels become dysregulated within a small focus of transformed cells
amid a differentiated epithelium. Conversely, this study does not suggest that normal
epithelial cells responding to physiologic levels of EGF as part of their normal growth cycle
will necessarily upregulate NKG2D ligands and thereby activate immune responses
unnecessarily. A similar consideration applied to the E2F-mediated induction of NKG2D
ligands in proliferating cells (19). Rather, it is more likely that acquired “immunological
visibility” is a general property of epithelial cells that are either responding to supra-
physiologic EGFR activation provoked by high levels of various “stressors”, or are
experiencing abortive cell proliferation cues, unable to balance their differentiated state with
chronic EGFR/MAP-kinase activation. Indeed, this may reflect the status of differentiated
cells following infection with a number of viruses, several of which express molecules that
suppress NKG2D-mediated immune-surveillance (61-64).
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Post-transcriptional regulation is increasingly acknowledged to play a major role in the
regulation of gene expression, particularly in response to environmental change. This has
been brought into focus by the identification of many non-coding RNAs that regulate coding
mRNAs in trans. However, ARE-mediated regulation remains a potent force, particularly in
immune responses where it also limits the expression of cytokines. A survey recently
identified seventeen categories of p37 AUF1-regulated genes, among which immunity and
defence genes were the ones with the highest statistical significance (65). Of note, in being
co-regulated by both EGF and AUF1, MICA segregates with a subset of profoundly
important biological functions, including CXCL5 and IL-11 (65-68) - two genes that, like
NKG2D ligands, are expressed by epithelial cells and have immuno-stimulatory potential.
Thus, one can view the data as further evidence that EGFR activation is de facto an
immunological regulator. Consistent with this, EGFR can be trans-activated following LPS
treatment (69), while two recently published papers described a large number of
immunological mediators acutely regulated, up or down, by clinical inhibitors of the EGFR
pathway, including Erlotinib (70, 71). Importantly, this impact on immune effectors could
be related to skin pathologies that commonly accompany therapeutic use of EGFR inhibitors
and which are a major problem in that they deter patient compliance. More specifically, the
common association of EGFR inhibitor usage with susceptibility to Staphylococcus aureus
and virus infection (72) would be consistent with defects in lymphoid stress surveillance
caused by EGFR inhibition and the consequent impairment of NKG2D ligand upregulation,
as predicted by this study. Indeed, there is widespread implication of the NKG2D pathway
in anti-viral defenses and EGFR is reportedly triggered by several Staphylococcus aureus
toxins (73-75) and by cytomegalovirus (CMV) infection (76), highlighting the potential
host-benefit of the EGFR being directly linked to lymphoid stress surveillance.
Consistent with the mechanism of ligand regulation elucidated in this study, and based on
the demonstrated lack of response of MHC Class I expression to EGFR activation, one may
conclude that the EGFR-mediated regulation of NKG2D ligands is somewhat specific.
Nonetheless, it must be noted that other authors have claimed that NKG2D ligand
expression can be up-regulated by application of Erlotinib to human cells including Caco-2
cells (77, 78). Because this seemingly contrasts with this study, the experiments described
here were repeated in multiple variations, but always with the same result; namely, the
suppression of any of several NKG2D ligands by Erlotinib and by other EGFR inhibitors,
consistent with the detailed molecular mechanism deduced. Possibly cells in other studies
had become so stressed by inhibitor treatment that secondary mechanisms began to affect
NKG2D ligand expression.
Importantly however, this study adds to several others that highlight that the capacity of
clinical inhibitors of the EGFR pathway to regulate immune surveillance may militate the
effects of those therapeutics, particularly given the capacity of a derepressed immune system
to be of therapeutic benefit to patients with solid and hematological tumors. This fuels the
view that EFGR, RTK, and MAPK pathways inhibitors that are used in caner should be
stratified according to their effects on immune surveillance. Moreover, the identification of
specific factors and mechanisms regulating human NKG2D ligands, as has been achieved
here, might facilitate the targeting of EGFR by strategies that do not impair NK cell and T
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cell recognition of tumors. The current study also argues for a clinical trial to test whether
therapeutics targeting RTKs might best be supplemented with immune enhancement, rather
than anti-inflammatories, as a means of promoting cancer therapy and reducing adverse
events such as defects in skin barrier protection.
Materials and Methods
Study Design
The core of the investigative approach was the comparison of NKG2D ligand RNA and
protein expression under defined circumstances. Because NKG2D ligand expression can be
perturbed by changes in cell growth conditions, all experiments were meticulously
controlled. Thus, the cell lines primarily employed (HaCat and Caco2) cease growth at
confluence owing to contact inhibition, and were subject to “stress” or growth factor
addition only after reaching confluence 48h beforehand. All control and experimental cell
aliquots were treated comparably, for example the cells’ temporary removal from incubators
for experimental or mock treatment, and their subsequent re-incubation in medium in which
they had been previously growing and that had been stored pro tem at 37°C. All experiments
were repeated independently, sometimes by different investigators (P.V; C.W; A.Turner)
over a period of time of over 5 years, and were internally controlled, such that all
conclusions reached could be based on the analysis of single experiments repeated several
times, rather than relying on comparisons across experiments. The sample sizes and
experimental repetitions were sufficient to permit rigorous statistical analysis as described in
the Figure legends and text, including correction for multiple parameter analysis for the
comparison of gene expression profiles. The specificity of reagents, particularly antibodies,
was verified.
Cells and culture conditions
Caco2, HCT116, Int407 and HeLa cells were from the ATCC; HaCat (immortalized human
keratinocytes). Polarized Caco2 monolayers were established as described (59). Primary
human keratinocytes were isolated as described (79) from human skin samples obtained as
discarded material after cutaneous surgery (St Thomas’ Hospital, London) under ethical
approval of the Guy’s and St Thomas’ NHS Foundation Trust Research Ethics Committee
(06/Q0704/18), adhering to the principles of the Declaration of Helsinki. All cells were
cultured in DMEM + 10% foetal calf serum (FCS), penicillin (50units/mL), streptomycin
(50μg/mL) and glutamine (2mM).
Primary murine keratinocytes were obtained from shaved mouse skin digested in a trypsin-
GNK solution for 2h to dissociate epidermis from dermis. The former was further digested
for 15min in trypsin-GNK and DNAse, filtered through a 70μm cell strainer, and washed 2×
with RPMI. Cells were plated at 106 cells/mL in Keratinocyte Serum-Free Medium (SFM)
supplemented with EGF in wells pre-coated with 50μg/mL rat-tail collagen type I (BD).
PBMC were isolated by Ficoll gradient centrifugation from blood obtained from healthy
volunteers after informed consent, according to the Declaration of Helsinki.
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Antibodies and reagents
A647 anti-MICA/B, APC anti-CD3, FITC anti-CD56, APC anti-HLA-E, PE anti-HLA-
A/B/C, blocking anti-NKG2D and all isotype control were from Biolegend. PE anti-MICA, -
MICB, ULBP1, -ULBP2 and -ULBP3 were from R&D systems. FITC anti-pan γδTCR was
from Beckman Coulter. PE anti-CD107a was from BD. Cetuximab (Erbitux) was from
Merck. Recombinant human EGF was from Calbiochem. All cell culture media and
reagents, Alexa 488 goat anti-rabbit IgG, and Prolongold were from Invitrogen. Chemical
inhibitors and rabbit polyclonal anti-AUF1 and anti-phosphoAUF1 were from Sigma-
Aldrich. The Dual Luciferase reporter system was from Promega.
Metabolic Labeling and Immunoprecipitation
Medium was replaced with methionine- and cysteine-free RPMI and 5% dialysed FCS for
1h. 150μCi of 35S labeled methionine/cysteine (Amersham) were added and cells cultured
for 6h at 37°C, 5% CO2. Cells were washed 3× with PBS and lysed with 1% NP40, 1mM
PMSF buffer containing 50μl/mL protease inhibitor cocktail (lysis buffer). Lysates were pre-
cleared for 2h at 4°C with Protein G Sepharose beads. Immunoprecipitation was carried out
overnight at 4°C with 2μg MICA monoclonal antibody coupled to Protein G Sepharose
beads. Beads were then washed 2× with lysis buffer and once with PBS. Sodium dodecyl
sulphate-polyacrylamide gel electrophoresis sample buffer was added; the samples boiled
for 5 minutes; and run on a 10% polyacrylamide gel. The gels were dried in a Bio-Rad gel
drier at 80°C for 1h and exposed to film.
UV irradiation
Cells were irradiated under a single Westinghouse FS20 tube (8cm from the source). The
dose was calibrated using a phototherapy radiometer (IL442A) and head SEE 1240. Medium
was removed from cells and stored at 37°C, monolayers were rinsed with pre-warmed PBS
and irradiation was carried out on cells covered with a meniscus of PBS. Following
irradiation, PBS was removed and the cells’ original medium that had been maintained pro
tem at 37°C was added back to the cells. Control cells were treated in identical fashion but
not irradiated.
RNA isolation and first strand cDNA synthesis
RNA was isolated using TRIzol reagent (Invitrogen) from cell monolayers lysed directly in
their flasks, followed by extraction with chloroform and precipitation with isopropanol. 5μg
of RNA were reverse transcribed for 1h in the presence of 500μM dNTPs, 25nM
oligo(dT)12-18 primer, 10μM DTT and 200 units Superscript II Reverse Transcriptase
(Invitrogen).
qPCR
Quantitative real-time PCR was carried out using the TaqMan system for cDNAs generated
from human cell lines. Primers and probes for MICA and MICB were designed using the
Primer-Express software (Perkin-Elmer). GAPDH primers and probe have been reported
(80). Amplicons were designed to cover an exon-exon boundary. Reporter and quencher
dyes were 6-carboxyfluorescein (FAM) and 6-carboxytetramethylrhodamine (TAMRA),
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respectively. For monitoring murine NKG2D ligand expression, the QuantiTect SYBR
Green PCR Kit was used (Qiagen). All qPCR primers are listed in Table S1A.
Plasmids, RT-PCR, cloning and generation of MICA-3′UTR mutants
pGL4.74 (encoding Renilla luciferase) was from Promega; pMax-FP-Green-N was from
Lonza. All molecular biology reagents were from New England Biolabs. PCR were
performed in 50μL with Phusion Taq DNA polymerase according to manufacturer’s
instructions. All primers are listed in Table S1B. AUF1 cDNA was cloned from HaCat cells.
The amplicon product (generated in the presence of 10% DMSO as the first exon contains
>80% GC) was directly digested with EcoRI and XhoI restriction enzymes, followed by
ligation into the pCR3.1 plasmid (Invitrogen). All four isoforms (p37, p40, p42, p45) were
obtained and their sequence verified. GFP reporter constructs were generated by overlapping
PCR. GFP was cloned from the pMax-FP-Green-N plasmid (primers GFP forward and
reverse) and the 3′UTR of MICA including all three polyA signals was amplified from
genomic DNA extracted from HeLa cells (primers GFP-M3U forward and reverse). 2μL of
both PCR products were used as a template for the overlapping PCR using primers, GFP
forward and GFP-M3U reverse. The resulting PCR product was cloned into pMax-FP-
Green-N using HindIII and AlfII restriction enzymes and the sequence verified. Mutants
were generated from this template by overlapping PCR using primers GFP forward, GFP-
M3U reverse, and the M3U-mut0 to M3U-mut3 primer pairs. Renilla luciferase reporter
constructs were generated in the same way, using the pGL4.74 plasmid and primers RLuc,
Rluc-M3U forward and reverse, and HindIII and BamHI restriction enzymes. All
transfections were carried out using Lipofectamine 2000 (Invitrogen) according to
manufacturer’s instructions.
Flow Cytometry
Cells were collected with PBS 10mM EDTA and stained in 50μL PBS 5% FCS (FACS
buffer) with the indicated antibodies (all used at a 1/100 final dilution) for 30mins at 4°C.
Cells were washed 2× with FACS buffer, and data acquired on a FACScalibur flow
cytometer (Becton Dickinson) and analyzed with FlowJo (Tree Star).
CD107a assay
Activation of effector cells by measuring the cell surface translocation of the CD107a
marker was performed as described previously (81), except that brefeldin A was omitted.
Briefly, target cells and PBMCs were mixed 1:1 in the presence of the PE anti-CD107a
antibody (1/30 final dilution) and incubated for 5h at 37°C and 5% CO2. Cells were washed
with FACS buffer and stained with combinations of APC anti-CD3 and FITC anti-CD56
(NK cells) or APC–anti-CD3 and FITC anti-pan γδTCR (γδ T cells), acquired and analyzed
as described above.
mRNA stability experiments
Confluent HaCat cells were serum-deprived overnight and treated (or not) with EGF (500ng/
mL). 5μg/mL Actinomycin D (Act.D, Sigma) was then added to replicate flasks, which were
subsequently harvested for mRNA extraction at defined time points. mRNA was quantified
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by spectrophotometry and 10μg of each sample separated on a 1.2% formalin-agarose gel
and transferred overnight onto nylon membranes (Hybond N+, Amersham) by capillary
blotting in 10× SSC. Blots were UV-crosslinked before hybridization. MICA, MICB and
GAPDH probes were prepared by PCR and labeled with α32P dCTP using Megaprime
labeling kit (Amersham) following manufacturer’s instructions. Probes were denatured at
95°C for 5min and hybridization was carried out in Expresshyb solution (Clontech)
following manufacturer’s instructions. Blots were incubated with probe in roller bottles for
1h at 68°C, washed with 2× SSC, 0.5% SDS at room temperature, then with 0.1× SSC, 0.1%
SDS at 50°C, and exposed to a storage phosphor screen and acquired using the Storm
PhosphorImager (Amersham). Bands were quantitated using ImageJ software.
Confocal Microscopy
HaCat cells were grown to confluence on 13mm coverslips placed in 24 well plates and
treated as described. Cells were then washed 2× with PBS, fixed for 20mins at room
temperature with BD CellFix buffer, washed 2× with PBS and permeabilised with PBS
0.1% Triton X-100 for 30mins. Cells were then incubated with primary and secondary
antibodies in PBS 0.02% Triton X-100 for 1h each, washed 2× with PBS and once in
ultrapure water, and then mounted on glass slides using 10μL Prolongold. Samples were
analysed using a TCS SP2 AOBS confocal microscope (equipped with an HCX PL APO CS
[confocal scanning], 63.0×/1.4 oil objective; Leica).
Analysis of gene expression in breast cancer samples and cell lines
The Human Exon 1.0 ST Affymetrix Array was used to generate the gene expression data of
172 primary breast carcinomas as described (53). Briefly, gene expression data were
normalized by using the quantile normalization method of Aroma Affymetrix package (82)
of the R software project (http://www.r-project.org/), followed by combat normalisation to
adjust for batch (83). The difference in gene expression of several NKG2D ligands was
determined between tumours with the lowest 25% EGFR, ESR1 or HER2 or highest 25%
LRIG1 and HNRNPD expression versus the remaining samples. Publicly available gene
expression data of 26 triple negative breast cancer cell lines was obtained from and pre-
processed as described (58). Probe sets with the highest variability across the dataset were
used as a representative for each gene (MICA, MICB, and EGFR). The association between
their gene expression levels was determined using Pearson’s Correlation.
Statistical analysis
Statistical significance for all experimental data was determined by paired or unpaired (as
indicated for each experiment) 2-tailed t-tests, using the Excel software (Microsoft).
Correlations between NKG2D ligands and EGFR, ESR2, HER2, LRIG1 and HNRNPD
expression in primary breast cancer samples and triple negative breast cancer cell lines were
analysed by Wilcoxon rank sum test and Pearson’s Correlation, respectively. The
appropriateness and correct implementation of the statistical tests was independently
verified.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We are grateful to Professor Antony Young (Department of Photobiology, St John’s Institute for Dermatology
(SJID) London, UK, for help during the early phases of this research, and to many colleagues for discussions.
HaCat cells were a kind gift from Dr. M. Allen (SJID). The monoclonal antibody to MICA (hu MIC-A-M673) for
immunoprecipitation was a kind gift of Dr. D. Cosman (Amgen Corporation). Primary human materials were
provided through the National Institutes of Health Research Biomedical Research Centre of Guy’s and St Thomas’
Hospital and King’s College London. Statistical tests were independently verified by Dr. L. Abeler-Dörner.
Funding: We thank CRUK (A.H and P.V), a Wellcome Trust Programme Grant (A.H); the European Community’s
Seventh Framework Programme FP7/2007-2013 under grant agreement #PIEF-GA-2009-255285 (P.V); the UK
Medical Research Council (C.S); and National Institute for Health Research (NIHR) Biomedical Research Centre at
Guy’s and St Thomas’ NHS Foundation Trust and King’s College London. (A.G and A. Tutt).
References
1. Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of
environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers
Prev. 2005; 14:1847–1850. [PubMed: 16103423]
2. Hayday AC. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity. 2009;
31:184–196. [PubMed: 19699170]
3. Nedellec S, Sabourin C, Bonneville M, Scotet E. NKG2D costimulates human V gamma 9V delta 2
T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-
induced calcium and transduction signals. J Immunol. 2010; 185:55–63. [PubMed: 20511557]
4. Rincon-Orozco B, et al. Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol. 2005;
175:2144–2151. [PubMed: 16081780]
5. Shafi S, et al. An NKG2D-mediated human lymphoid stress surveillance response with high
interindividual variation. Sci Transl Med. 2011; 3:113ra124.
6. Petukhova L, et al. Genome-wide association study in alopecia areata implicates both innate and
adaptive immunity. Nature. 2010; 466:113–117. [PubMed: 20596022]
7. Tsoi LC, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate
immunity. Nat Genet. 2012; 44:1341–1348. [PubMed: 23143594]
8. Nausch N, Cerwenka A. NKG2D ligands in tumor immunity. Oncogene. 2008; 27:5944–5958.
[PubMed: 18836475]
9. Fernandez-Messina L, et al. Differential mechanisms of shedding of the
glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands. J Biol Chem. 2010; 285:8543–8551.
[PubMed: 20080967]
10. Waldhauer I, et al. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 2008;
68:6368–6376. [PubMed: 18676862]
11. Wilkinson GW, et al. Modulation of natural killer cells by human cytomegalovirus. J Clin Virol.
2008; 41:206–212. [PubMed: 18069056]
12. Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune
system ligands of the NKG2D receptor. Nature. 2005; 436:1186–1190. [PubMed: 15995699]
13. Molinero LL, et al. Activation-induced expression of MICA on T lymphocytes involves
engagement of CD3 and CD28. J Leukoc Biol. 2002; 71:791–797. [PubMed: 11994503]
14. Yamamoto K, et al. Oxidative stress increases MICA and MICB gene expression in the human
colon carcinoma cell line (CaCo-2). Biochim Biophys Acta. 2001; 1526:10–12. [PubMed:
11287116]
15. Zou Y, Bresnahan W, Taylor RT, Stastny P. Effect of human cytomegalovirus on expression of
MHC class I-related chains A. J Immunol. 2005; 174:3098–3104. [PubMed: 15728525]
Vantourout et al. Page 17
Sci Transl Med. Author manuscript; available in PMC 2014 October 09.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
16. Bahram S, Inoko H, Shiina T, Radosavljevic M. MIC and other NKG2D ligands: from none to too
many. Curr Opin Immunol. 2005; 17:505–509. [PubMed: 16087327]
17. Lanca T, et al. The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/
lymphoma susceptibility to gammadelta T-cell cytotoxicity. Blood. 2010; 115:2407–2411.
[PubMed: 20101024]
18. Eagle RA, Trowsdale J. Promiscuity and the single receptor: NKG2D. Nat Rev Immunol. 2007;
7:737–744. [PubMed: 17673918]
19. Jung H, et al. RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors,
which control cell cycle entry. J Exp Med. 2012; 209:2409–2422. [PubMed: 23166357]
20. Groh V, et al. Cell stress-regulated human major histocompatibility complex class I gene expressed
in gastrointestinal epithelium. Proc Natl Acad Sci U S A. 1996; 93:12445–12450. [PubMed:
8901601]
21. Raulet DH, et al. Regulation of Ligands for the NKG2D Activating Receptor. Annu Rev Immunol.
2013
22. Stern-Ginossar N, et al. Human microRNAs regulate stress-induced immune responses mediated
by the receptor NKG2D. Nat Immunol. 2008; 9:1065–1073. [PubMed: 18677316]
23. Yadav D, et al. Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by
IFN-gamma-induced microRNA. J Immunol. 2009; 182:39–43. [PubMed: 19109132]
24. Zhang H, et al. ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Invest. 2007;
117:2051–2058. [PubMed: 17671639]
25. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major
histocompatibility complex class I genes. Proc Natl Acad Sci U S A. 1994; 91:6259–6263.
[PubMed: 8022771]
26. Boukamp P, et al. Normal keratinization in a spontaneously immortalized aneuploid human
keratinocyte cell line. J Cell Biol. 1988; 106:761–771. [PubMed: 2450098]
27. Aoki-Yoshida A, Aoki R, Takayama Y. Protective effect of pyruvate against UVB-induced
damage in HaCaT human keratinocytes. J Biosci Bioeng. 2013; 115:442–448. [PubMed:
23219088]
28. Fernau NS, et al. Role of HuR and p38MAPK in ultraviolet B-induced post-transcriptional
regulation of COX-2 expression in the human keratinocyte cell line HaCaT. J Biol Chem. 2010;
285:3896–3904. [PubMed: 19917608]
29. Huang HC, Chang TM, Chang YJ, Wen HY. UVB irradiation regulates ERK1/2- and p53-
dependent thrombomodulin expression in human keratinocytes. PLoS One. 2013; 8:e67632.
[PubMed: 23844043]
30. Li L, et al. Selection of reference genes for gene expression studies in ultraviolet B-irradiated
human skin fibroblasts using quantitative real-time PCR. BMC Mol Biol. 2011; 12:8. [PubMed:
21324211]
31. Momparler RL, Karon M, Siegel SE, Avila F. Effect of adriamycin on DNA, RNA, and protein
synthesis in cell-free systems and intact cells. Cancer Res. 1976; 36:2891–2895. [PubMed:
1277199]
32. Frenkel EP, Skinner WN, Smiley JD. Studies on a Metabolic Defect Induced by Hydroxyurea
(Nsc-32065). Cancer Chemother Rep. 1964; 40:19–22. [PubMed: 14206907]
33. Matsushima T, Kobuna I, Sugimura T. In vivo interaction of 4-nitroquinoline-1-oxide and its
derivatives with DNA. Nature. 1967; 216:508. [PubMed: 4293602]
34. el-Deiry WS, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75:817–825.
[PubMed: 8242752]
35. Zheng ZS, Chen RZ, Prystowsky JH. UVB radiation induces phosphorylation of the epidermal
growth factor receptor, decreases EGF binding and blocks EGF induction of ornithine
decarboxylase gene expression in SV40-transformed human keratinocytes. Exp Dermatol. 1993;
2:257–265. [PubMed: 8162346]
36. Lund LR, et al. Transcriptional and post-transcriptional regulation of the receptor for urokinase-
type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell
line A549. Biochem J. 1995; 310(Pt 1):345–352. [PubMed: 7646466]
Vantourout et al. Page 18
Sci Transl Med. Author manuscript; available in PMC 2014 October 09.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
37. Marschall C, et al. UVB increases urokinase-type plasminogen activator receptor (uPAR)
expression. J Invest Dermatol. 1999; 113:69–76. [PubMed: 10417621]
38. van Houdt WJ, et al. Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth
factor receptor inhibition and activation. Neoplasia. 2010; 12:443–452. [PubMed: 20563247]
39. Cheng H, et al. Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations
of sorbitol. J Cell Physiol. 2002; 192:234–243. [PubMed: 12115730]
40. Knebel A, Rahmsdorf HJ, Ullrich A, Herrlich P. Dephosphorylation of receptor tyrosine kinases as
target of regulation by radiation, oxidants or alkylating agents. EMBO J. 1996; 15:5314–5325.
[PubMed: 8895576]
41. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA
mediates selective mRNA degradation. Cell. 1986; 46:659–667. [PubMed: 3488815]
42. Chen CY, Shyu AB. AU-rich elements: characterization and importance in mRNA degradation.
Trends Biochem Sci. 1995; 20:465–470. [PubMed: 8578590]
43. Proudfoot NJ. Ending the message: poly(A) signals then and now. Genes Dev. 2011; 25:1770–
1782. [PubMed: 21896654]
44. Tian B, Hu J, Zhang H, Lutz CS. A large-scale analysis of mRNA polyadenylation of human and
mouse genes. Nucleic Acids Res. 2005; 33:201–212. [PubMed: 15647503]
45. Clark A, Dean J, Tudor C, Saklatvala J. Post-transcriptional gene regulation by MAP kinases via
AU-rich elements. Front Biosci. 2009; 14:847–871.
46. White EJ, Brewer G, Wilson GM. Post-transcriptional control of gene expression by AUF1:
mechanisms, physiological targets, and regulation. Biochim Biophys Acta. 2013; 1829:680–688.
[PubMed: 23246978]
47. Zucconi BE, Wilson GM. Modulation of neoplastic gene regulatory pathways by the RNA-binding
factor AUF1. Front Biosci (Landmark Ed). 2011; 16:2307–2325. [PubMed: 21622178]
48. David PS, Tanveer R, Port JD. FRET-detectable interactions between the ARE binding proteins,
HuR and p37AUF1. RNA. 2007; 13:1453–1468. [PubMed: 17626845]
49. Chen CY, Xu N, Zhu W, Shyu AB. Functional dissection of hnRNP D suggests that nuclear import
is required before hnRNP D can modulate mRNA turnover in the cytoplasm. RNA. 2004; 10:669–
680. [PubMed: 15037776]
50. Aigner A, et al. Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2
in serum of testicular cancer patients. Ann Oncol. 2003; 14:1525–1529. [PubMed: 14504053]
51. Balcan E, et al. Serum levels of epidermal growth factor, transforming growth factor, and c-erbB2
in ovarian cancer. Int J Gynecol Cancer. 2012; 22:1138–1142. [PubMed: 22914212]
52. Kim BK, et al. The multiplex bead array approach to identifying serum biomarkers associated with
breast cancer. Breast Cancer Res. 2009; 11:R22. [PubMed: 19400944]
53. Gazinska P, et al. Comparison of basal-like triple-negative breast cancer defined by morphology,
immunohistochemistry and transcriptional profiles. Mod Pathol. 2013
54. Jacot W, et al. The HER2 amplicon in breast cancer: Topoisomerase IIA and beyond. Biochim
Biophys Acta. 2013; 1836:146–157. [PubMed: 23628726]
55. Masuda H, et al. Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res
Treat. 2012; 136:331–345. [PubMed: 23073759]
56. Renoir JM, Marsaud V, Lazennec G. Estrogen receptor signaling as a target for novel breast cancer
therapeutics. Biochem Pharmacol. 2013; 85:449–465. [PubMed: 23103568]
57. Laederich MB, et al. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family
receptor tyrosine kinases. J Biol Chem. 2004; 279:47050–47056. [PubMed: 15345710]
58. Neve RM, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer
subtypes. Cancer Cell. 2006; 10:515–527. [PubMed: 17157791]
59. Ou G, et al. Contribution of intestinal epithelial cells to innate immunity of the human gut--studies
on polarized monolayers of colon carcinoma cells. Scand J Immunol. 2009; 69:150–161.
[PubMed: 19170965]
60. Gerlinger M, et al. Intratumor heterogeneity and branched evolution revealed by multiregion
sequencing. N Engl J Med. 2012; 366:883–892. [PubMed: 22397650]
Vantourout et al. Page 19
Sci Transl Med. Author manuscript; available in PMC 2014 October 09.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
61. Chalupny NJ, Rein-Weston A, Dosch S, Cosman D. Down-regulation of the NKG2D ligand MICA
by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun. 2006;
346:175–181. [PubMed: 16750166]
62. Cosman D, et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16
and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 2001; 14:123–133.
[PubMed: 11239445]
63. Matusali G, et al. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and
impair NKG2D expression and cytotoxicity of NK cells. FASEB J. 2013; 27:2440–2450.
[PubMed: 23395909]
64. Thomas M, et al. Down-regulation of NKG2D and NKp80 ligands by Kaposi’s sarcoma-associated
herpesvirus K5 protects against NK cell cytotoxicity. Proc Natl Acad Sci U S A. 2008; 105:1656–
1661. [PubMed: 18230726]
65. Wu X, et al. Combinatorial mRNA binding by AUF1 and Argonaute 2 controls decay of selected
target mRNAs. Nucleic Acids Res. 2013; 41:2644–2658. [PubMed: 23303783]
66. Furugaki K, et al. Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer
cell line NCI-H292. Clin Exp Metastasis. 2011; 28:649–659. [PubMed: 21688034]
67. Lal A, et al. Concurrent versus individual binding of HuR and AUF1 to common labile target
mRNAs. EMBO J. 2004; 23:3092–3102. [PubMed: 15257295]
68. McMellen ME, et al. Epidermal growth factor receptor signaling modulates chemokine (CXC)
ligand 5 expression and is associated with villus angiogenesis after small bowel resection. Surgery.
2010; 148:364–370. [PubMed: 20471049]
69. Hsu D, et al. Toll-like receptor 4 differentially regulates epidermal growth factor-related growth
factors in response to intestinal mucosal injury. Lab Invest. 2010; 90:1295–1305. [PubMed:
20498653]
70. Lichtenberger BM, et al. Epidermal EGFR Controls Cutaneous Host Defense and Prevents
Inflammation. Sci Transl Med. 2013; 5:199ra111.
71. Mascia F, et al. Genetic Ablation of Epidermal EGFR Reveals the Dynamic Origin of Adverse
Effects of Anti-EGFR Therapy. Sci Transl Med. 2013; 5:199ra110.
72. Eilers RE Jr. et al. Dermatologic infections in cancer patients treated with epidermal growth factor
receptor inhibitor therapy. J Natl Cancer Inst. 2010; 102:47–53. [PubMed: 20007525]
73. Breshears LM, Schlievert PM, Peterson ML. A disintegrin and metalloproteinase 17 (ADAM17)
and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to
Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1). J Biol Chem. 2012; 287:32578–
32587. [PubMed: 22833676]
74. Gomez MI, Seaghdha MO, Prince AS. Staphylococcus aureus protein A activates TACE through
EGFR-dependent signaling. EMBO J. 2007; 26:701–709. [PubMed: 17255933]
75. Haugwitz U, et al. Pore-forming Staphylococcus aureus alpha-toxin triggers epidermal growth
factor receptor-dependent proliferation. Cell Microbiol. 2006; 8:1591–1600. [PubMed: 16984414]
76. Wang X, et al. Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus.
Nature. 2003; 424:456–461. [PubMed: 12879076]
77. Bae JH, et al. Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced
by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1
induction. Cancer Sci. 2012; 103:7–16. [PubMed: 21951556]
78. He S, et al. Enhanced interaction between natural killer cells and lung cancer cells: involvement in
gefitinib-mediated immunoregulation. J Transl Med. 2013; 11:186. [PubMed: 23937717]
79. Modi BG, et al. Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma.
Science. 2012; 335:104–108. [PubMed: 22223807]
80. Barbany G, et al. Manifold-assisted reverse transcription-PCR with real-time detection for
measurement of the BCR-ABL fusion transcript in chronic myeloid leukemia patients. Clin Chem.
2000; 46:913–920. [PubMed: 10894833]
81. Betts MR, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow
cytometric assay for degranulation. J Immunol Methods. 2003; 281:65–78. [PubMed: 14580882]
82. Bengtsson H, Irizarry R, Carvalho B, Speed TP. Estimation and assessment of raw copy numbers
at the single locus level. Bioinformatics. 2008; 24:759–767. [PubMed: 18204055]
Vantourout et al. Page 20
Sci Transl Med. Author manuscript; available in PMC 2014 October 09.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
83. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using
empirical Bayes methods. Biostatistics. 2007; 8:118–127. [PubMed: 16632515]
Vantourout et al. Page 21
Sci Transl Med. Author manuscript; available in PMC 2014 October 09.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 1. UVB upregulates NKG2D ligand expression via EGFR
(A) Confluent HaCat cells were untreated (control) or exposed to UVB (60mJ/cm2) or heat shock (HS, 90mins 42°C), labelled
with 35S-methionine/cysteine immediately after HS and 24h post-UVB, and lysed. MICA immunoprecipitates were analysed
relative to known size markers (kD) by SDS-PAGE and autoradiography. (B) Confluent HaCat (top) or Int407 (bottom) cells
were untreated or exposed to UVB. RNA was extracted 24h later and MICA quantified relative to GAPDH by real-time qPCR.
Data were compiled from 9 (HaCat) and 4 (Int407) independent experiments. Numbers in italic indicate p values (paired t-test).
(C) Primary human keratinocytes were untreated (Mock) or UVB-irradiated (60mJ/cm2) and MICA/B and ULBP2 expression
monitored by flow cytometry 24h post-treatment. Numbers in italic indicate respective MFI values. (D) Confluent HaCat cells
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were exposed to UVB or treated with doxorubicin (Dox, 1μg/mL), hydroxyurea (HUrea, 1mM) or 4NQO (1μg/mL). MICA
expression was monitored as in B. Each dot represents the analysis of an individual sample. Numbers in italic indicate p values
relative to control (unpaired t-test). (E) Confluent HaCat cells were untreated (control) or treated with the EGFR inhibitor
AG1478 (AG) alone or 30mins prior to UVB irradiation (left); or serum-deprived overnight and incubated +/− EGF (500ng/mL,
right), and mRNA levels quantified as in B. Results from 5 independent experiments are shown. Numbers in italic indicate p
values (paired t-test). (F) Confluent primary murine keratinocytes in serum free medium (SFM) were untreated or stimulated
with EGF (100ng/mL) for 24h (left). As a positive control for Rae1b and H60a upregulation, cells were UVB irradiated (right).
Expression was monitored by real-time qPCR. Data were normalized to cyclophilin and expressed as the mean of three
treatments +/− SD. Numbers in italic indicate p values (unpaired t-test).
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Figure 2. Cell surface expression of NKG2D ligands is upregulated by EGF and cellular stresses
(A) Confluent HaCat, Caco-2 and HCT116 cells were serum-deprived overnight and stimulated with 500 ng/mL EGF (dark blue
and red histograms) or left in serum-free medium (SFM) (light blue and red histograms) for 24h and cell surface expression of
the indicated NKG2D ligands monitored by flow cytometry. Data are representative of at least 3 independent experiments (iso =
isotype control staining). (B) HaCat and HCT116 cells were treated as in A (see Figure S2D for assesement of NKG2D ligand
expression) and then co-incubated for 5h at 37°C with PBMCfrom 3 healthy donors (HD1-3) in the presence of PE-conjugated
anti-CD107a antibody and a blocking anti-NKG2D or isotype control antibody (10μg/mL). Cells were washed and stained with
APC-anti-CD3 and FITC-anti-pan TCRγδ, or with APC anti-CD3 and FITC anti-CD56 to analyse responses of γδ T and NK
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cells, respectively (see Figure S3 for gating controls). Data are means of triplicate stimulations +/− SD. Numbers in italic
indicate p values (unpaired t-test). (C) HaCat cells serum-deprived overnight were treated with EGF (500ng/mL), Sorbitol
(Sorb, 0.5M) or hydrogen peroxide (H2O2, 0.6mM) with or without a 1h pre-treatment with AG1478 (AG, 10μM). Surface
MICA, MICB and ULBP2 expression levels were monitored 24h later by FACS. Data normalized to untreated cells (ctrl) and
expressed as means of three treatments +/− SD. Numbers in italics are p values (unpaired t-test).
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Figure 3. MICA mRNA stability is regulated by its 3′UTR
(A) HaCat cells were serum-deprived and incubated overnight with or without EGF (500ng/mL). Actinomycin D was added and
RNA extracted at the indicated time points [t (h)] for northern analysis. The blot was probed for MICA and MICB, and re-
probed for GAPDH. Representative of 3 experiments. Densitometry analysis was performed with ImageJ and raw values are
indicated in italics for each sample (ND, not detectable). See Figure S5A for the evaluation of mRNA half-lives (B) The
sequence of the full 3′UTR of MICA was deduced from cloning and sequencing and from the genomic sequence (accession
number NC_000006.11) to include poly-A signals (underlined), relative to which the poly-A processing site identified by re-
sequencing (blue) shows a different location than the previously identified site (yellow) (see also Figure S6A). Also shown are
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microRNA seeding sites (green) and a canonical ARE (bold). (C) HaCat cells were transfected with the pMax-FP-Green
plasmid (GFP) or a modified version including the 3′UTR of MICA (GFP-M3U). GFP expression was monitored by flow
cytometry 24h post-transfection. Plots are representative of 3 independent transfections. Numbers in italic indicate MFI. (D)
HaCat and HCT116 cells were transfected as in B. Medium was supplemented 24h post-transfection with G418 (0.5mg/mL).
After 14 days, confluent cells were serum-deprived overnight and further treated (or not) with EGF for 24h before GFP
expression was analyzed by flow cytometry. Data were normalized to untreated cells for each transfectant and are means of
triplicate EGF treatments +/− SD. Numbers in italic indicate p values (unpaired t-test).
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Figure 4. The ARE and AUF1 destabilize MICA mRNA
(A) HaCat cells were transfected with plasmids encoding Renilla luciferase (Rluc, pGL4.74, Ctrl) or modified versions
including the wild-type (wt) or mutated (M3Umut0 to M3Umut3) 3′UTR of MICA and co-transfected with a plasmid encoding
Firefly luciferase (Fluc) as an internal control. At 24h post-transfection, luciferase activity was measured using a Dual-
Luciferase reporter assay system, and luminescence values for Rluc normalized to the internal Fluc values and to the wt Rluc
control. Data are the mean of three independent transfections +/− SD. Numbers in italic indicate p values (unpaired t-test).
Relevant sequences are indicated, including the miRNA seeding site (italic), ARE (bold) and mutations generated (red). (B)
HaCat cells were mock-transfected, or transfected with pCR3.1 plasmids either empty or encoding each AUF1 isoform as
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indicated. Cell-surface expression of MICA, MICB and ULBP2 was analyzed by flow cytometry at 36h post-transfection. Data
are normalized to mock-transfected cells expressed as the mean of three transfections +/− SD. Numbers in italic indicate p
values (unpaired t-test). (C) HaCat cells grown on coverslips were treated as indicated, fixed and permeabilized, stained for
endogenous AUF1, and analysed by confocal microscopy. Images are representative of 3 independent experiments and show
overlays of AUF1 (green) and DAPI staining (blue) (see Figure S9B for individual channels).
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Figure 5. The EGFR-mediated upregulation of NKG2D ligand upregulation has clinical implications
(A) Expression of NKG2D ligands in primary breast cancers with the bottom 25% (B25) EGFR or top 25% (T25) LRIG1 and
HNRNPD gene expression compared to the remaining samples. Numbers in italic indicate p values (Wilcoxon rank sum test).
(B) HaCat cells were grown to confluence, serum-deprived for 24h, treated or not with EGF (500ng/mL) for 24h with or without
a 1h pre-treatment with Erlotinib (10μM), and stained for MICA, MICB and ULBP2. Data normalized to untreated cells
(control) and expressed as the mean of three treatments +/− SD. Numbers in italic indicate p values (unpaired t-test). (C)
Actively growing subconfluent HaCat cells grown in complete medium were treated or not with increasing doses of Erlotinib for
24h and stained for MICA, MICB and ULBP2. Data were normalized to untreated cells and are means of three treatments +/−
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SD. (D) Differentiated Caco-2 monolayers grown on collagen-coated transwell inserts until establishing electrically-resistant
epithelial sheets were serum-deprived overnight, treated (or not) with EGF (500ng/mL) for 24h with or without a 1h pre-
treatment with Erlotinib (10μM), and stained for MICA/B and ULBP2. Numbers in italic indicate MFI.
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Figure 6. The EGFR pathway induces NKG2D ligand upregulation via the abrogation of AUF1-mediated mRNA destabilization
(A) Under normal conditions, NKG2D ligand mRNAs are constitutively targeted by AUF1 for degradation via their AU-Rich
Elements. (B) Activation of the EGFR, either by its ligand or by any of several physico-chemical stresses leads activates the
MEK pathway and the exclusion of AUF1 from the nucleus, allowing NKG2D ligand mRNAs to be stabilized and translated
and the proteins to be expressed at the cell surface, where they may engage NKG2D on cytolytic lymphocytes.
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